Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $2.95 Million - $3.41 Million
10,719 New
10,719 $3.05 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $1.83 Million - $2.09 Million
-7,136 Reduced 70.39%
3,002 $834,000
Q4 2022

Feb 10, 2023

SELL
$252.44 - $306.72 $779,282 - $946,844
-3,087 Reduced 23.34%
10,138 $2.81 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $2.13 Million - $2.93 Million
10,930 Added 476.25%
13,225 $3.53 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $452,721 - $538,370
-2,414 Reduced 51.26%
2,295 $468,000
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $912,462 - $1.15 Million
4,709 New
4,709 $992,000
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $856,717 - $1.1 Million
-3,826 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $785,580 - $1.02 Million
2,776 Added 264.38%
3,826 $1.08 Million
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $409,997 - $656,485
-1,583 Reduced 60.12%
1,050 $364,000
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $1.26 Million - $1.48 Million
-5,188 Reduced 66.33%
2,633 $737,000
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $96,866 - $145,808
410 Added 5.53%
7,821 $1.92 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $585,671 - $676,230
-2,212 Reduced 22.99%
7,411 $2.1 Million
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $131,140 - $173,672
507 Added 5.56%
9,623 $2.57 Million
Q1 2020

May 08, 2020

SELL
$268.85 - $341.04 $1.98 Million - $2.51 Million
-7,365 Reduced 44.69%
9,116 $2.88 Million
Q4 2019

Feb 07, 2020

BUY
$220.06 - $304.07 $584,479 - $807,609
2,656 Added 19.21%
16,481 $4.89 Million
Q3 2019

Nov 08, 2019

BUY
$217.44 - $243.88 $688,415 - $772,124
3,166 Added 29.7%
13,825 $3.22 Million
Q2 2019

Aug 09, 2019

BUY
$219.29 - $241.72 $2.34 Million - $2.58 Million
10,659 New
10,659 $2.49 Million
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $1.81 Million - $2.83 Million
-8,338 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$278.5 - $352.75 $594,597 - $753,121
2,135 Added 34.42%
8,338 $2.51 Million
Q3 2018

Nov 09, 2018

SELL
$293.51 - $383.83 $1.83 Million - $2.4 Million
-6,244 Reduced 50.16%
6,203 $2.19 Million
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $882,005 - $1.05 Million
-3,425 Reduced 21.58%
12,447 $3.61 Million
Q1 2018

May 11, 2018

BUY
$260.13 - $367.91 $2 Million - $2.83 Million
7,687 Added 93.92%
15,872 $4.35 Million
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $546,983 - $612,663
1,778 Added 27.75%
8,185 $2.61 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $1.8 Million - $2.11 Million
6,407
6,407 $2.01 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.